glp 1 approved for nash Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty liver disease? Akero's NASH therapy, paired with

Perhaps the most important agenda item is in discussion on whether to keep this just an Ozempic case or to include other manufacturers such as those who made Rybelsus, Wegovy, Trulicity, and Mounjaro

Ear and her colleagues encourage patients with neuroendocrine cancer to talk with their doctors before using a GLP-1 receptor agonist.

Nutrients , 9 (11), 1211

GLP-1 medications carry a boxed warning regarding the risk of thyroid cancer, specifically medullary thyroid carcinoma (MTC)

This meal sequencing strategy, eating protein first, has been shown to improve postprandial GLP-1 response and glucose control in multiple studies